Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic

We found that patients who visit a memory clinic and carry a pathogenic genetic variant are often not eligible for genetic testing. The proposed new criteria improve the identification of patients with a genetic cause for their cognitive complaints. In systems without practical or financial barriers to genetic testing, the new criteria can enhance personalized care. In other countries where the health care systems differs and in other genetic ancestry groups, the performance of the criteria may be different.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-01-27
DOI
https://doi.org/10.1212/wnl.0000000000210273
Citations
6
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
9.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic

Marc Hulsman, Rosalina van Spaendonk, Itziar de Rojas, Wiesje M. van der Flier et al.
6 citations
Neurology
Genetics and Neurodevelopmental Disorders
9.09
article

Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic

Marc Hulsman, Rosalina van Spaendonk, Itziar de Rojas, Wiesje M. van der Flier, Mieke M. van Haelst, Mariet W. Elting, Henne Holstege, Fred van Ruissen, Marcel Reinders, Corien C. Verschuuren‐Bemelmans, Sven J. van der Lee, Christa de Geus, Janna I.R. Dijkstra, Jetske van der Schaar, Yolande A.L. Pijnenburg, Niccoló Tesi
article en
6 citations

Abstract

We found that patients who visit a memory clinic and carry a pathogenic genetic variant are often not eligible for genetic testing. The proposed new criteria improve the identification of patients with a genetic cause for their cognitive complaints. In systems without practical or financial barriers to genetic testing, the new criteria can enhance personalized care. In other countries where the health care systems differs and in other genetic ancestry groups, the performance of the criteria may be different.

NeurologyVol. 104(4)
University Medical Center Groningen (NL), University of Groningen (NL), Instituto de Salud Carlos III (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Center for Personalized Cancer Treatment (NL), Amsterdam Neuroscience (NL), Fundació ACE (ES), Amsterdam University Medical Centers (NL), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL), Delft University of Technology (NL)
Openalex Percentile: Top 3%
Genetics and Neurodevelopmental Disorders
9.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.